Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05464251 · ClinicalTrials.gov registry record
Prospective Analysis of Spinal Epidural Abscess
A clinical trial of Spinal Epidural Abscess, sponsored by Francis Farhadi.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT05464251 is a study of Spinal Epidural Abscess that is actively recruiting participants, run by Francis Farhadi. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05464251, a study of Spinal Epidural Abscess, is actively recruiting participants, sponsored by Francis Farhadi.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective study involving all patients treated at the University of Kentucky for spinal epidural abscess over a 2-year period. Based on ongoing referrals of patients with SEA, we expect that 200 patients will be enrolled during this time window. We propose to study all available clinical, pathological, radiological, and socioeconomic data of patients diagnosed with a spinal infection with or without a history of drug abuse over this study period. All patients' charts will be prospectively reviewed starting at the time of presentation for a period of 1 year.
Conditions Studied
Interventions
- OTHER Prospective chart review of subjects diagnosed with spinal epidural abscess
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-07-12 |
| Est. Completion | 2027-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05464251
The ClinicalTrials.gov registry entry for NCT05464251 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Francis Farhadi, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spinal Epidural Abscess appearing as the primary indexed condition, and to 1 intervention - of which Prospective chart review of subjects diagnosed with spinal epidural abscess is the first listed.
NCT05464251 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT05464251 about?
NCT05464251 is a clinical study titled "Prospective Analysis of Spinal Epidural Abscess". This is a prospective study involving all patients treated at the University of Kentucky for spinal epidural abscess over a 2-year period. Based on ongoing referrals of patients with SEA, we expect that 200 patients will be enrolled during this time window. We propose to study all available clinical...
What is the current status of trial NCT05464251?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2022-07-12. Estimated completion is 2027-06.
What conditions does trial NCT05464251 study?
This clinical trial studies the following conditions: Spinal Epidural Abscess.
What interventions are being tested in trial NCT05464251?
The interventions under investigation include: Prospective chart review of subjects diagnosed with spinal epidural abscess (OTHER).
Who is sponsoring clinical trial NCT05464251?
This trial is sponsored by Francis Farhadi, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05464251 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.